NCT07216885

Solv Multi-Pass Hemodialysis System In-Center Clinical Study

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 46 (estimated)
• Sponsor: Mozarc Medical US LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Solv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration. Eligibility will be open to incident dialysis patients and patients currently receiving HD in an in-center environment. All vascular access types including AV-fistula, AV-graft, and tunneled hemodialysis catheters.

Conditions

• End Stage Renal Disease

Interventions

Type	Name	Description
DEVICE	Solv Multi-Pass Hemodialysis System	Solv Multi-Pass Hemodialysis System

Timeline

• Start date: 2026-01-13
• Primary completion: 2026-07-01
• Completion: 2026-07-01
• First posted: 2025-10-15
• Last updated: 2026-04-01

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study